Research Interests
-
Dr. Devi’s research interests include functional genomics, anti-cancer drug discovery and development, mechanisms of cancer cell signaling, tumor immunity and applications thereof for overcoming therapeutic resistance in cancer.
The lab has established prostate, inflammatory breast cancer and ovarian cellular and tumor models. More info
Publications
- Devi, Gayathri R., Pritha Pai, Seayoung Lee, Matthew W. Foster, Dorababu S. Sannareddy, Francois Bertucci, Naoto Ueno, and Steven Van Laere. “Altered ribosomal profile in acquired resistance and reversal associates with pathological response to chemotherapy in inflammatory breast cancer.” NPJ Breast Cancer 10, no. 1 (July 29, 2024): 65. https://doi.org/10.1038/s41523-024-00664-0.More info
- Van Berckelaer, Christophe, Steven Van Laere, Seayoung Lee, Michael A. Morse, Joseph Geradts, Luc Dirix, Mark Kockx, François Bertucci, Peter Van Dam, and Gayathri R. Devi. “XIAP overexpressing inflammatory breast cancer patients have high infiltration of immunosuppressive subsets and increased TNFR1 signaling targetable with Birinapant.” Transl Oncol 43 (May 2024): 101907. https://doi.org/10.1016/j.tranon.2024.101907.More info
- Devi, Gayathri R., Laura J. Fish, Alexandra Bennion, Gregory E. Sawin, Sarah M. Weaver, Katherine Reddy, Rashmi Saincher, and Anh N. Tran. “Identification of barriers at the primary care provider level to improve inflammatory breast cancer diagnosis and management.” Prev Med Rep 36 (December 2023): 102519. https://doi.org/10.1016/j.pmedr.2023.102519.More info
- Gearhart-Serna, Larisa M., Brittany A. Mills, Hillary Hsu, Oluwadamilola M. Fayanju, Kate Hoffman, and Gayathri R. Devi. “Cumulative environmental quality is associated with breast cancer incidence differentially by summary stage and urbanicity.” Sci Rep 13, no. 1 (November 20, 2023): 20301. https://doi.org/10.1038/s41598-023-45693-0.More info
- Arun, K., M. Vignesh, and G. R. Devi. “Comparison of novel tin coated and uncoated carbide tool in CNC dry turning of aisi H13 to maximize material removal rate.” In AIP Conference Proceedings, Vol. 2822, 2023. https://doi.org/10.1063/5.0177003.More info
- Vamsidhar, K., M. Vignesh, and G. R. Devi. “Comparison of novel tin coated and uncoated carbide tool in CNC wet turning of EN31 to maximize material removal rate.” In AIP Conference Proceedings, Vol. 2822, 2023. https://doi.org/10.1063/5.0173215.More info
- Rickard, Ashlyn G., Dorababu S. Sannareddy, Alexandra Bennion, Pranalee Patel, Scott J. Sauer, Douglas C. Rouse, Samantha Bouchal, et al. “A Novel Preclinical Murine Model to Monitor Inflammatory Breast Cancer Tumor Growth and Lymphovascular Invasion.” Cancers (Basel) 15, no. 8 (April 12, 2023). https://doi.org/10.3390/cancers15082261.More info
- Gearhart-Serna, Larisa M., Kate Hoffman, Hillary Hsu, and Gayathri R. Devi. “Abstract 4217: Cumulative environmental quality is associated with breast cancer incidence differentially by summary stage and urbanicity.” In Cancer Research, 83:4217–4217. American Association for Cancer Research (AACR), 2023. https://doi.org/10.1158/1538-7445.am2023-4217.More info
- Devi, Gayathri R., Dorababu Sannareddy, Alexandra Bennion, Ashlyn Rickard, Douglas C. Rouse, Mark W. Dewhirst, and Gregory M. Palmer. “Abstract P3-08-06: Monitoring Lymphovascular Invasion and Tumor Growth of Inflammatory Breast Cancer in a Murine Lymphatic Reporter Window Chamber Model.” In Cancer Research, Vol. 83. American Association for Cancer Research (AACR), 2023. https://doi.org/10.1158/1538-7445.sabcs22-p3-08-06.More info
- Gearhart-Serna, Larisa M., Hillary Hsu, Oluwadamilola Lola Fayanju, Brittany Mills, Kate Hoffman, and Gayathri R. Devi. “Abstract P4-03-12: Cumulative Environmental Quality is Associated with Differential Breast Cancer Incidence by Summary Stage and Urbanicity.” In Cancer Research, Vol. 83. American Association for Cancer Research (AACR), 2023. https://doi.org/10.1158/1538-7445.sabcs22-p4-03-12.More info
- Devi, Gayathri R., Laura J. Fish, Alexandra Bennion, Sarah Weaver, Gregory Sawin, and Anh N. Tran. “Abstract B045: Assessing knowledge and barriers at the primary care provider level that contribute to disparities in inflammatory breast cancer diagnosis and treatment.” In Cancer Epidemiology, Biomarkers & Prevention, 32:B045–B045. American Association for Cancer Research (AACR), 2023. https://doi.org/10.1158/1538-7755.disp22-b045.More info
- Devi, G. R., D. Praveen, B. Bhuvaneswari, M. Hariharan, and N. N. Sre. “Automatic Paddy Drying Robot.” In 2023 International Conference on System, Computation, Automation and Networking, ICSCAN 2023, 2023. https://doi.org/10.1109/ICSCAN58655.2023.10395570.More info
- Devi, G. R., S. Athiyan, K. I. Thamizh, and V. H. Varthini. “Speed and Distance Detection for Highway Traffic using Python.” In 2023 International Conference on System, Computation, Automation and Networking, ICSCAN 2023, 2023. https://doi.org/10.1109/ICSCAN58655.2023.10395447.More info
- Devi, Gayathri, Laura Fish, Alexandra Bennion, Gregory Sawin, Sarah Weaver, and Anh Tran. “Assessing Knowledge and Barriers at the Primary Care Provider Level that Contribute to Disparities in Inflammatory Breast Cancer Diagnosis and Treatment.” Res Sq, December 5, 2022. https://doi.org/10.21203/rs.3.rs-2302308/v1.More info
- Al Abo, Muthana, Larisa Gearhart-Serna, Steven Van Laere, Jennifer A. Freedman, Steven R. Patierno, Eun-Sil Shelley Hwang, Savitri Krishnamurthy, Kevin P. Williams, and Gayathri R. Devi. “Adaptive stress response genes associated with breast cancer subtypes and survival outcomes reveal race-related differences.” NPJ Breast Cancer 8, no. 1 (June 13, 2022): 73. https://doi.org/10.1038/s41523-022-00431-z.More info
- Van Berckelaer, Christophe, Steven Van Laere, Joseph Gerardts, Luc Dirix, Michael Morse, Mark Kockx, François Bertucci, Peter Van Dam, and Gayathri R. Devi. “Abstract P1-04-07: Xiap expression is associated with infiltration of cd163+ tumor-associated macrophages in the tumor micro-environment of inflammatory breast cancer.” In Cancer Research, Vol. 82. American Association for Cancer Research (AACR), 2022. https://doi.org/10.1158/1538-7445.sabcs21-p1-04-07.More info
- Rypens, Charlotte, François Bertucci, Pascal Finetti, Fredika Robertson, Sandra V. Fernandez, Naoto Ueno, Wendy A. Woodward, et al. “Comparative transcriptional analyses of preclinical models and patient samples reveal MYC and RELA driven expression patterns that define the molecular landscape of IBC.” NPJ Breast Cancer 8, no. 1 (January 18, 2022): 12. https://doi.org/10.1038/s41523-021-00379-6.More info
- Schirmer, Amelia U., Lucy M. Driver, Megan T. Zhao, Carrow I. Wells, Julie E. Pickett, Sean N. O’Bryne, Benjamin J. Eduful, et al. “Non-canonical role of Hippo tumor suppressor serine/threonine kinase 3 STK3 in prostate cancer.” Mol Ther 30, no. 1 (January 5, 2022): 485–500. https://doi.org/10.1016/j.ymthe.2021.08.029.More info
- Gearhart-Serna, Larisa M., Moises Tacam, Theodore A. Slotkin, and Gayathri R. Devi. “Analysis of polycyclic aromatic hydrocarbon intake in the US adult population from NHANES 2005-2014 identifies vulnerable subpopulations, suggests interaction between tobacco smoke exposure and sociodemographic factors.” Environ Res 201 (October 2021): 111614. https://doi.org/10.1016/j.envres.2021.111614.More info
- Devi, Gayathri R., Pascal Finetti, Michael A. Morse, Seayoung Lee, Alexandre de Nonneville, Steven Van Laere, Jesse Troy, Joseph Geradts, Shannon McCall, and Francois Bertucci. “Expression of X-Linked Inhibitor of Apoptosis Protein (XIAP) in Breast Cancer Is Associated with Shorter Survival and Resistance to Chemotherapy.” Cancers (Basel) 13, no. 11 (June 4, 2021). https://doi.org/10.3390/cancers13112807.More info
- Song, Mingqing, Zachary W. Fitch, Kannan P. Samy, Benjamin M. Martin, Qimeng Gao, Robert Patrick Davis, Francis V. Leopardi, et al. “Coagulation, inflammation, and CD46 transgene expression in neonatal porcine islet xenotransplantation.” Xenotransplantation 28, no. 3 (May 2021): e12680. https://doi.org/10.1111/xen.12680.More info
- Xie, Xuemei, Jangsoon Lee, Huey Liu, Troy Pearson, Alexander Y. Lu, Debu Tripathy, Gayathri R. Devi, Chandra Bartholomeusz, and Naoto T. Ueno. “Birinapant Enhances Gemcitabine's Antitumor Efficacy in Triple-Negative Breast Cancer by Inducing Intrinsic Pathway-Dependent Apoptosis.” Mol Cancer Ther 20, no. 2 (February 2021): 296–306. https://doi.org/10.1158/1535-7163.MCT-19-1160.More info
- Sauer, Scott, Dylan Beinart, Sade M. B. Finn, Sereena L. Kumar, Qing Cheng, Shelley E. Hwang, William Parker, and Gayathri R. Devi. “Hymenolepis diminuta-based helminth therapy in C3(1)-TAg mice does not alter breast tumor onset or progression.” Evol Med Public Health 9, no. 1 (2021): 131–38. https://doi.org/10.1093/emph/eoab007.More info
- Gearhart-Serna, Larisa M., John B. Davis, Mohit Kumar Jolly, Nishad Jayasundara, Scott J. Sauer, Richard T. Di Giulio, and Gayathri R. Devi. “A polycyclic aromatic hydrocarbon-enriched environmental chemical mixture enhances AhR, antiapoptotic signaling and a proliferative phenotype in breast cancer cells.” Carcinogenesis 41, no. 12 (December 31, 2020): 1648–59. https://doi.org/10.1093/carcin/bgaa047.More info
- Oldham, Carla E., M. J. Gathings, Gayathri R. Devi, Steven R. Patierno, Kevin P. Williams, Holly J. Hough, and Nadine J. Barrett. “An innovative educational program for addressing health disparities in translational cancer research.” J Clin Transl Sci 5, no. 1 (November 5, 2020): e65. https://doi.org/10.1017/cts.2020.555.More info
- Gearhart-Serna, Larisa M., Kate Hoffman, and Gayathri R. Devi. “Environmental Quality and Invasive Breast Cancer.” Cancer Epidemiol Biomarkers Prev 29, no. 10 (October 2020): 1920–28. https://doi.org/10.1158/1055-9965.EPI-19-1497.More info
- Xie, Xuemei, Jangsoon Lee, Troy Pearson, Alexander Y. Lu, Debu Tripathy, Gayathri R. Devi, Chandra Bartholomeusz, and Naoto T. Ueno. “Abstract 548: Birinapant enhances gemcitabine's anti-tumor efficacy in triple-negative breast cancer by inducing intrinsic pathway-dependent apoptosis.” In Cancer Research, 80:548–548. American Association for Cancer Research (AACR), 2020. https://doi.org/10.1158/1538-7445.am2020-548.More info
- Devi, Gayathri R., Muthana Al Abo, Larisa Gearhart-Serna, Joseph Geradts, Shannon J. McCall, and Savitri Krishnamurthy. “Abstract B035: Identification of a tumor cell adaptive stress response signaling pathway, which drives aggressive breast cancer phenotype and therapeutic resistance, in African American patients with locally advanced breast cancer subtypes.” In Cancer Epidemiology, Biomarkers & Prevention, 29:B035–B035. American Association for Cancer Research (AACR), 2020. https://doi.org/10.1158/1538-7755.disp19-b035.More info
- Gearhart-Serna, Larisa M., Kate Hoffman, and Gayathri R. Devi. “Abstract B122: Spatial analysis of ductal carcinoma in situ, locoregional, and distant metastatic breast cancer in North Carolina: Evidence for rural-urban disparities.” In Cancer Epidemiology, Biomarkers & Prevention, 29:B122–B122. American Association for Cancer Research (AACR), 2020. https://doi.org/10.1158/1538-7755.disp19-b122.More info
- Dixon, Maria S., Lhoucine Chdid, David R. Lamson, Michael T. Tarpley, Helen O. Oladapo, Jodie M. Fleming, Jennifer A. Freedman, Gayathri R. Devi, and Kevin P. Williams. “Abstract C100: Identification and functional characterization of a novel GLI1 splice variant in breast cancer.” In Cancer Epidemiology, Biomarkers & Prevention, 29:C100–C100. American Association for Cancer Research (AACR), 2020. https://doi.org/10.1158/1538-7755.disp18-c100.More info
- Gearhart-Serna, Larisa M., Moises Tacam, Theodore A. Slotkin, and Gayathri R. Devi. “Abstract D093: Who carries the excess cancer risk burden: Implications of disparities in polycyclic aromatic hydrocarbon exposure.” In Cancer Epidemiology, Biomarkers & Prevention, 29:D093–D093. American Association for Cancer Research (AACR), 2020. https://doi.org/10.1158/1538-7755.disp19-d093.More info
- Williams, Kevin P., Nadine J. Barrett, Carla E. Oldham, Holly Hough, Artis Woodard, Jennifer Freedman, Gayathri R. Devi, and Steven R. Patierno. “Abstract IA18: North Carolina Central University and Duke Cancer Institute's collaborative cancer research and education program: Connecting cancer disparities translational research, clinical trials operations, and community engagement.” In Cancer Epidemiology, Biomarkers & Prevention, 29:IA18–IA18. American Association for Cancer Research (AACR), 2020. https://doi.org/10.1158/1538-7755.disp18-ia18.More info
- Devi, Gayathri R., Whitney Lane, Holly J. Hough, Kearston L. Ingraham, Larisa Gearhart, and Nadine J. Barrett. “Current unmet needs in inflammatory breast cancer/IBC patient care: Analysis of open-ended responses from a community engagement session of clinicians, researchers, advocates, and patients at the Duke Consortium for IBC conference.” In CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, Vol. 29, 2020.More info
- Dixon, Maria S., Lhoucine Chdid, David R. Lamson, Michael T. Tarpley, Helen O. Oladapo, Jodie M. Fleming, Jennifer A. Freedman, Gayathri R. Devi, and Kevin P. Williams. “Identification and functional characterization of a novel GLI1 splice variant in breast cancer.” In CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, Vol. 29, 2020.More info
- Dixion, Maria, Kearston L. Ingraham, Seronda A. Robinson, Jodie M. Fleming, Gayathri R. Devi, Holly Hough, Hamzah Kharabsheh, et al. “Results from a town hall meeting: Inflammatory breast cancer listening session led by KOMEN scholars.” In CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, Vol. 29, 2020.More info
- Dixion, Maria, Kearston L. Ingraham, Seronda A. Robinson, Jodie M. Fleming, Gayathri R. Devi, Holly Hough, Hamzah Kharabsheh, et al. “Abstract A023: Results from a town hall meeting: Inflammatory breast cancer listening session led by KOMEN scholars.” In Cancer Epidemiology, Biomarkers & Prevention, 29:A023–A023. American Association for Cancer Research (AACR), 2020. https://doi.org/10.1158/1538-7755.disp18-a023.More info
- Devi, Gayathri R., Whitney Lane, Holly J. Hough, Kearston L. Ingraham, Larisa Gearhart, and Nadine J. Barrett. “Abstract A038: Current unmet needs in inflammatory breast cancer/IBC patient care: Analysis of open-ended responses from a community engagement session of clinicians, researchers, advocates, and patients at the Duke Consortium for IBC conference.” In Cancer Epidemiology, Biomarkers & Prevention, 29:A038–A038. American Association for Cancer Research (AACR), 2020. https://doi.org/10.1158/1538-7755.disp18-a038.More info
- Gerahart-Serna, Larisa, Whitney Lane, Laura Fish, Anh N. Tran, Gayathri R. Devi, Holly Hough, and Kearston L. Ingraham. “Abstract B034: Improving patient-centered care for inflammatory breast cancer: Strategies for addressing barriers faced by patients, researchers, and providers.” In Cancer Epidemiology, Biomarkers & Prevention, 29:B034–B034. American Association for Cancer Research (AACR), 2020. https://doi.org/10.1158/1538-7755.disp19-b034.More info
- Rypens, Charlotte, Melike Marsan, Christophe Van Berckelaer, Charlotte Billiet, Kirsten Melis, Sara Perez Lopez, Peter van Dam, et al. “Inflammatory breast cancer cells are characterized by abrogated TGFβ1-dependent cell motility and SMAD3 activity.” Breast Cancer Res Treat 180, no. 2 (April 2020): 385–95. https://doi.org/10.1007/s10549-020-05571-z.More info
- Rickard, Ashlyn, Pranalee Patel, Scott J. Sauer, Mark W. Dewhirst, Gregory M. Palmer, and Gayathri R. Devi. “Abstract P1-03-03: Multichannel serial imaging of transgenic, preclinical murine models provides the first quantitative analysis of the unusual growth kinetics and lymph-vascular invasion of patient-derived inflammatory breast cancer cells and tumor emboli.” In Cancer Research, Vol. 80. American Association for Cancer Research (AACR), 2020. https://doi.org/10.1158/1538-7445.sabcs19-p1-03-03.More info
- Fayanju, Oluwadamilola M., Yi Ren, Rachel A. Greenup, Jennifer K. Plichta, Laura H. Rosenberger, Jeremy Force, Gita Suneja, et al. “Extent of axillary surgery in inflammatory breast cancer: a survival analysis of 3500 patients.” Breast Cancer Res Treat 180, no. 1 (February 2020): 207–17. https://doi.org/10.1007/s10549-020-05529-1.More info
- Devi, G. R., Z. Fitch, M. Song, M. Ribeiro, A. McGowan, X. Luo, B. H. Collins, and A. D. Kirk. “XIAP Enhances Xenoislet Survival: Novel Models to Evaluate Pretransplantation Gene Modifications.” In AMERICAN JOURNAL OF TRANSPLANTATION, 20:741–741, 2020.More info
- Gearhart-Serna, Larisa M., Kate Hoffman, Brittany A. Mills, and Gayathri R. Devi. “North Carolina environmental quality is associated with distant/metastatic breast cancer: Evidence for rural-urban disparities.” In CANCER PREVENTION RESEARCH, 13:27–28, 2020.More info
- Samy, Kannan P., Qimeng Gao, Robert Patrick Davis, Mingqing Song, Zachary W. Fitch, Michael S. Mulvihill, Andrea L. MacDonald, et al. “The role of human CD46 in early xenoislet engraftment in a dual transplant model.” Xenotransplantation 26, no. 6 (November 2019): e12540. https://doi.org/10.1111/xen.12540.More info
- Devi, G. R., D. V. Lakshmi, and N. N. Gandhi. “Removal of 2, 4 dichlorophenol from aqueous medium using chemically modified low-cost adsorbent: Kinetics, isotherm, thermodynamics and regeneration studies.” In Desalination and Water Treatment, 156:331–39, 2019. https://doi.org/10.5004/dwt.2019.23863.More info
- Song, M., K. Samy, Q. Gao, R. P. Davis, F. Leopard, Z. Fitch, C. Bennett, G. R. Devi, B. H. Collins, and A. D. Kirk. “CD46 Transgene Modification and Thrombosis in Neonatal Porcine Islet Xenotransplantation.” In AMERICAN JOURNAL OF TRANSPLANTATION, 19:430–430. WILEY, 2019.More info
- Fitch, Z. W., Q. Gao, R. P. Davis, M. S. Mulvihill, M. Song, F. Leopardi, M. Ribeiro, et al. “Islet Xenotransplantation: A Quest for Clinically Available Immunosuppression Regimens.” In AMERICAN JOURNAL OF TRANSPLANTATION, 19:473–74. WILEY, 2019.More info
- Bocci, Federico, Larisa Gearhart-Serna, Marcelo Boareto, Mariana Ribeiro, Eshel Ben-Jacob, Gayathri R. Devi, Herbert Levine, José Nelson Onuchic, and Mohit Kumar Jolly. “Toward understanding cancer stem cell heterogeneity in the tumor microenvironment.” Proc Natl Acad Sci U S A 116, no. 1 (January 2, 2019): 148–57. https://doi.org/10.1073/pnas.1815345116.More info
- Gearhart-Serna, L. M., J. B. Davis, N. Jayasundara, M. K. Jolly, S. J. Sauer, H. Levine, R. T. Di Giulio, and G. R. Devi. “Exposure to a Naturally Occurring Polycyclic Aromatic Hydrocarbon Mixture Triggers an Aggressive Phenotype in Estrogen Receptor-Positive Breast Cancer Cells.” In INTERNATIONAL JOURNAL OF TOXICOLOGY, 38:37–38. SAGE PUBLICATIONS INC, 2019.More info
- Devi, Gayathri R., Holly Hough, Nadine Barrett, Massimo Cristofanilli, Beth Overmoyer, Neil Spector, Naoto T. Ueno, et al. “Perspectives on Inflammatory Breast Cancer (IBC) Research, Clinical Management and Community Engagement from the Duke IBC Consortium.” J Cancer 10, no. 15 (2019): 3344–51. https://doi.org/10.7150/jca.31176.More info
- Ramya Devi, Gopalakrishnan, and Kayaroganam Palanikumar. “Analysis on drilling of woven glass fibre reinforced aluminium sandwich laminates.” Journal of Materials Research and Technology 8, no. 1 (January 2019): 1024–35. https://doi.org/10.1016/j.jmrt.2018.06.021.More info
- Oladapo, Helen, Xiaojia Ji, Hassan Shehata, Mike Tarpley, Lhoucine Chdid, David Lamson, Xuhui Bao, Scott Sauer, Gayathri R. Devi, and Kevin P. Williams. “Efficacy of GLI antagonists in triple-negative inflammatory breast cancer 2D and 3D models.” In CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 27:131–32. AMER ASSOC CANCER RESEARCH, 2018.More info
- Patel, Pranalee, Ben Mirman, Renzhi Zhan, and Gayathri R. Devi. “Abstract 4854: Targeting ribonucleotide reductase M2 using didox causes inhibition of estrogen receptor-negative, inflammatory breast cancer cell proliferation and tumor emboli formation in culture.” In Cancer Research, 78:4854–4854. American Association for Cancer Research (AACR), 2018. https://doi.org/10.1158/1538-7445.am2018-4854.More info
- Evans, Myron K., Michael C. Brown, Joseph Geradts, Xuhui Bao, Timothy J. Robinson, Mohit Kumar Jolly, Peter B. Vermeulen, et al. “XIAP Regulation by MNK Links MAPK and NFκB Signaling to Determine an Aggressive Breast Cancer Phenotype.” Cancer Res 78, no. 7 (April 1, 2018): 1726–38. https://doi.org/10.1158/0008-5472.CAN-17-1667.More info
- Samy, K. P., R. P. Davis, Q. Gao, B. M. Martin, M. Song, J. Cano, A. B. Farris, et al. “Early barriers to neonatal porcine islet engraftment in a dual transplant model.” Am J Transplant 18, no. 4 (April 2018): 998–1006. https://doi.org/10.1111/ajt.14601.More info
- Freel, Stephanie A., Laura J. Fish, Benjamin Mirman, Ranjan Sudan, and Gayathri R. Devi. “Advancement of multidisciplinary education and research in translational sciences: MERITS program development at Duke University.” J Clin Transl Sci 2, no. 1 (February 2018): 57–62. https://doi.org/10.1017/cts.2018.17.More info
- Gearhart-Serna, Larisa M., Nishad Jayasundara, Moises Tacam, Richard Di Giulio, and Gayathri R. Devi. “Assessing Cancer Risk Associated with Aquatic Polycyclic Aromatic Hydrocarbon Pollution Reveals Dietary Routes of Exposure and Vulnerable Populations.” J Environ Public Health 2018 (2018): 5610462. https://doi.org/10.1155/2018/5610462.More info
- Oladapo, Helen O., Michael Tarpley, Scott J. Sauer, Kezia A. Addo, Shalonda M. Ingram, Dillon Strepay, Ben K. Ehe, et al. “Pharmacological targeting of GLI1 inhibits proliferation, tumor emboli formation and in vivo tumor growth of inflammatory breast cancer cells.” Cancer Lett 411 (December 28, 2017): 136–49. https://doi.org/10.1016/j.canlet.2017.09.033.More info
- Arora, Jay, Scott J. Sauer, Michael Tarpley, Peter Vermeulen, Charlotte Rypens, Steven Van Laere, Kevin P. Williams, Gayathri R. Devi, and Mark W. Dewhirst. “Inflammatory breast cancer tumor emboli express high levels of anti-apoptotic proteins: use of a quantitative high content and high-throughput 3D IBC spheroid assay to identify targeting strategies.” Oncotarget 8, no. 16 (April 18, 2017): 25848–63. https://doi.org/10.18632/oncotarget.15667.More info
- Arora, Jay, Scott J. Sauer, Michael Tarpley, Peter Vermeulen, Charlotte Rypens, Steven Van Laere, Kevin P. Williams, Gayathri R. Devi, and Mark W. Dewhirst. “Inflammatory breast cancer tumor emboli express high levels of anti-apoptotic proteins: use of a quantitative high content and high-throughput 3D IBC spheroid assay to identify targeting strategies.” ONCOTARGET 8, no. 16 (April 18, 2017): 25848–63.More info
- Shammas, Ronnie L., Andrew M. Fales, Bridget M. Crawford, Amy J. Wisdom, Gayathri R. Devi, David A. Brown, Tuan Vo-Dinh, and Scott T. Hollenbeck. “Human Adipose-Derived Stem Cells Labeled with Plasmonic Gold Nanostars for Cellular Tracking and Photothermal Cancer Cell Ablation.” Plast Reconstr Surg 139, no. 4 (April 2017): 900e-910e. https://doi.org/10.1097/PRS.0000000000003187.More info
- Sauer, Scott J., Michael Tarpley, Imran Shah, Akshay V. Save, H Kim Lyerly, Steven R. Patierno, Kevin P. Williams, and Gayathri R. Devi. “Bisphenol A activates EGFR and ERK promoting proliferation, tumor spheroid formation and resistance to EGFR pathway inhibition in estrogen receptor-negative inflammatory breast cancer cells.” Carcinogenesis 38, no. 3 (March 1, 2017): 252–60. https://doi.org/10.1093/carcin/bgx003.More info
- Shammas, R. L., A. M. Fales, B. M. Crawford, S. T. Hollenbeck, T. Vo-Dinh, and G. R. Devi. “Abstract P3-16-02: Nanotheranostics using plasmonic gold nanostars to target inflammatory breast cancer cells and tumor emboli.” In Cancer Research, Vol. 77. American Association for Cancer Research (AACR), 2017. https://doi.org/10.1158/1538-7445.sabcs16-p3-16-02.More info
- Devi, Gayathri R., Eun-Sil Shelley Hwang, John Stewart, Michael A. Morse, and Steven Van Laere. “Abstract B44: Immune pathway dysregulations in inflammatory breast cancer health disparity.” In Cancer Epidemiology, Biomarkers & Prevention, 26:B44–B44. American Association for Cancer Research (AACR), 2017. https://doi.org/10.1158/1538-7755.disp16-b44.More info
- Crawford, Bridget M., Ronnie L. Shammas, Andrew M. Fales, David A. Brown, Scott T. Hollenbeck, Tuan Vo-Dinh, and Gayathri R. Devi. “Photothermal ablation of inflammatory breast cancer tumor emboli using plasmonic gold nanostars.” Int J Nanomedicine 12 (2017): 6259–72. https://doi.org/10.2147/IJN.S141164.More info
- Woodward, Wendy A., Massimo Cristofanilli, Sofia D. Merajver, Steven Van Laere, Lajos Pusztai, Francois Bertucci, Fedor Berditchevski, et al. “Scientific Summary from the Morgan Welch MD Anderson Cancer Center Inflammatory Breast Cancer (IBC) Program 10th Anniversary Conference.” J Cancer 8, no. 17 (2017): 3607–14. https://doi.org/10.7150/jca.21200.More info
- Evans, Myron K., Joseph Geradts, Courtney Edwards, Arianna Price, Arjun J. Arora, Amy J. Aldrich, Adrian Ramirez, et al. “Abstract LB-015: XIAP induction by the MAPK-eIF4G1 pathway drives NFκB activation in inflammatory breast cancer growth and therapeutic resistance.” In Cancer Research, Vol. 76. American Association for Cancer Research (AACR), 2016. https://doi.org/10.1158/1538-7445.am2016-lb-015.More info
- Nath, Sritama, and Gayathri R. Devi. “Three-dimensional culture systems in cancer research: Focus on tumor spheroid model.” Pharmacol Ther 163 (July 2016): 94–108. https://doi.org/10.1016/j.pharmthera.2016.03.013.More info
- Evans, M. K., S. J. Sauer, S. Nath, T. J. Robinson, M. A. Morse, and G. R. Devi. “X-linked inhibitor of apoptosis protein mediates tumor cell resistance to antibody-dependent cellular cytotoxicity.” Cell Death Dis 7, no. 1 (January 28, 2016): e2073. https://doi.org/10.1038/cddis.2015.412.More info
- Devi, Gayathri R., and Sritama Nath. “Delivery of Synthetic mRNA Encoding FOXP3 Antigen into Dendritic Cells for Inflammatory Breast Cancer Immunotherapy.” Methods Mol Biol 1428 (2016): 231–43. https://doi.org/10.1007/978-1-4939-3625-0_15.More info
- Evans, Myron K., Scott J. Sauer, Amy J. Aldrich, Joseph Geradts, Peter Vermeulen, Luc Dirix, Steven Van Laere, and Gayathri R. Devi. “Abstract P6-14-05: A novel link between anti-apoptotic signaling, NFκB, and SMAD7 in IBC pathobiology.” In Cancer Research, Vol. 75. American Association for Cancer Research (AACR), 2015. https://doi.org/10.1158/1538-7445.sabcs14-p6-14-05.More info
- Betof, Allison S., Christopher D. Lascola, Douglas Weitzel, Chelsea Landon, Peter M. Scarbrough, Gayathri R. Devi, Gregory Palmer, Lee W. Jones, and Mark W. Dewhirst. “Modulation of murine breast tumor vascularity, hypoxia and chemotherapeutic response by exercise.” J Natl Cancer Inst 107, no. 5 (May 2015). https://doi.org/10.1093/jnci/djv040.More info
- Devi, G. R., J. L. Allensworth, M. Evans, N. Ueno, D. McDonnell, F. Bertucci, and S. Van Laere. “80 Determination of an oxidative stress gene signature in inflammatory breast cancer patient tumors and development of a novel redox modulatory strategy in overcoming chemotherapy resistance and mediating anti-tumor efficacy.” In European Journal of Cancer, 50:31–31. Elsevier BV, 2014. https://doi.org/10.1016/s0959-8049(14)70206-0.More info
- Sauer, Scott Jeffrey, John B. Davis, H Kim Lyerly, Imran Shah, Kevin P. Williams, and Gayathri R. Devi. “Bisphenol a Interacts with Gper, Activates EGFR and ERK Signaling and Antagonizes Efficacy of Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors in Breast Cancer Cells.” ENDOCRINE REVIEWS 35, no. 3 (June 1, 2014).More info
- Evans, Myron K., Artak Tovmasyan, Ines Batinic-Haberle, and Gayathri R. Devi. “Mn porphyrin in combination with ascorbate acts as a pro-oxidant and mediates caspase-independent cancer cell death.” Free Radic Biol Med 68 (March 2014): 302–14. https://doi.org/10.1016/j.freeradbiomed.2013.11.031.More info
- Devi, G. R., J. L. Allensworth, M. K. Evans, and S. J. Sauer. “The Role of Oxidative Stress in Breast Cancer.” In Cancer: Oxidative Stress and Dietary Antioxidants, 3–14, 2014. https://doi.org/10.1016/B978-0-12-405205-5.00001-5.More info
- Devi, Gayathri R., Jennifer L. Allensworth, Shalonda M. Ingram, Ginger R. Smith, Amy J. Aldrich, and Kevin P. Williams. “Abstract 951: Cross-resistance and re-sensitization to multiple drugs in an IBC model of lapatinib acquired resistance parallels redox adaptation.” In Cancer Research, 73:951–951. American Association for Cancer Research (AACR), 2013. https://doi.org/10.1158/1538-7445.am2013-951.More info
- Nair, Smita, Amy J. Aldrich, Eoin McDonnell, Qing Cheng, Anshu Aggarwal, Pujan Patel, Monique M. Williams, et al. “Immunologic targeting of FOXP3 in inflammatory breast cancer cells.” PLoS One 8, no. 1 (2013): e53150. https://doi.org/10.1371/journal.pone.0053150.More info
- Osada, Takuya, Peter Berglund, Michael A. Morse, Bolyn Hubby, Whitney Lewis, Donna Niedzwiecki, Xiao Yi Yang, et al. “Co-delivery of antigen and IL-12 by Venezuelan equine encephalitis virus replicon particles enhances antigen-specific immune responses and antitumor effects.” Cancer Immunol Immunother 61, no. 11 (November 2012): 1941–51. https://doi.org/10.1007/s00262-012-1248-y.More info
- Devi, G. R., J. L. Allensworth, S. J. Sauer, M. M. Morse, and H. K. Lyerly. “101 Smac Mimetic Induces Apoptosis and Synergizes with TRAIL in Inflammatory Breast Cancer Cells in an IAP-Dependent and TNF-a-Independent Mechanism.” In European Journal of Cancer, 48:32–32. Elsevier BV, 2012. https://doi.org/10.1016/s0959-8049(12)71899-3.More info
- Rangwala, Fatima, Kevin P. Williams, Ginger R. Smith, Zainab Thomas, Jennifer L. Allensworth, H Kim Lyerly, Anna Mae Diehl, Michael A. Morse, and Gayathri R. Devi. “Differential effects of arsenic trioxide on chemosensitization in human hepatic tumor and stellate cell lines.” BMC Cancer 12 (September 10, 2012): 402. https://doi.org/10.1186/1471-2407-12-402.More info
- Allensworth, Jennifer L., Katherine M. Aird, Amy J. Aldrich, Ines Batinic-Haberle, and Gayathri R. Devi. “XIAP inhibition and generation of reactive oxygen species enhances TRAIL sensitivity in inflammatory breast cancer cells.” Mol Cancer Ther 11, no. 7 (July 2012): 1518–27. https://doi.org/10.1158/1535-7163.MCT-11-0787.More info
- Piacentino, Valentino, Carmelo A. Milano, Michael Bolanos, Jacob Schroder, Emily Messina, Adam S. Cockrell, Edward Jones, et al. “X-linked inhibitor of apoptosis protein-mediated attenuation of apoptosis, using a novel cardiac-enhanced adeno-associated viral vector.” Hum Gene Ther 23, no. 6 (June 2012): 635–46. https://doi.org/10.1089/hum.2011.186.More info
- Aird, Katherine M., Jennifer L. Allensworth, Ines Batinic-Haberle, H Kim Lyerly, Mark W. Dewhirst, and Gayathri R. Devi. “ErbB1/2 tyrosine kinase inhibitor mediates oxidative stress-induced apoptosis in inflammatory breast cancer cells.” Breast Cancer Res Treat 132, no. 1 (February 2012): 109–19. https://doi.org/10.1007/s10549-011-1568-1.More info
- Morse, M. A., A. Hobeika, D. Serra, K. Aird, M. McKinney, A. Aldrich, T. Clay, et al. “Depleting regulatory T cells with arginine-rich, cell-penetrating, peptide-conjugated morpholino oligomer targeting FOXP3 inhibits regulatory T-cell function.” Cancer Gene Ther 19, no. 1 (January 2012): 30–37. https://doi.org/10.1038/cgt.2011.63.More info
- Ye, Xiaodong, Diane Fels, Artak Tovmasyan, Katherine M. Aird, Casey Dedeugd, Jennifer L. Allensworth, Ivan Kos, et al. “Cytotoxic effects of Mn(III) N-alkylpyridylporphyrins in the presence of cellular reductant, ascorbate.” Free Radic Res 45, no. 11–12 (November 2011): 1289–1306. https://doi.org/10.3109/10715762.2011.616199.More info
- Thomas, Z. I., W. Gibson, J. Z. Sexton, K. M. Aird, S. M. Ingram, A. Aldrich, H. K. Lyerly, G. R. Devi, and K. P. Williams. “Targeting GLI1 expression in human inflammatory breast cancer cells enhances apoptosis and attenuates migration.” Br J Cancer 104, no. 10 (May 10, 2011): 1575–86. https://doi.org/10.1038/bjc.2011.133.More info
- Clay, Timothy M., Takuya Osada, Zachary C. Hartman, Amy Hobeika, Gayathri Devi, Michael A. Morse, and H Kim Lyerly. “Polyclonal immune responses to antigens associated with cancer signaling pathways and new strategies to enhance cancer vaccines.” Immunol Res 49, no. 1–3 (April 2011): 235–47. https://doi.org/10.1007/s12026-010-8186-6.More info
- Gupta, Seema, Tulay Koru-Sengul, Susanne M. Arnold, Gayathri R. Devi, Mohammed Mohiuddin, and Mansoor M. Ahmed. “Low-dose fractionated radiation potentiates the effects of cisplatin independent of the hyper-radiation sensitivity in human lung cancer cells.” Mol Cancer Ther 10, no. 2 (February 2011): 292–302. https://doi.org/10.1158/1535-7163.MCT-10-0630.More info
- Allensworth, J. L., K. M. Aird, M. B. Murray, and G. R. Devi. “Abstract P1-04-01: X-Linked Inhibitor of Apoptosis Protein (XIAP) Regulates TRAIL-Induced Apoptosis in Inflammatory Breast Cancer Cells.” Cancer Research 70, no. 24_Supplement (December 15, 2010). https://doi.org/10.1158/0008-5472.sabcs10-p1-04-01.More info
- Morse, Michael A., Amy C. Hobeika, Takuya Osada, Peter Berglund, Bolyn Hubby, Sarah Negri, Donna Niedzwiecki, et al. “An alphavirus vector overcomes the presence of neutralizing antibodies and elevated numbers of Tregs to induce immune responses in humans with advanced cancer.” J Clin Invest 120, no. 9 (September 2010): 3234–41. https://doi.org/10.1172/JCI42672.More info
- Morse, Michael A., Junping Wei, Zachary Hartman, Wenle Xia, Xiu-Rong Ren, Gangjun Lei, William T. Barry, et al. “Synergism from combined immunologic and pharmacologic inhibition of HER2 in vivo.” Int J Cancer 126, no. 12 (June 15, 2010): 2893–2903. https://doi.org/10.1002/ijc.24995.More info
- Aird, Katherine M., Rami B. Ghanayem, Sharon Peplinski, Herbert K. Lyerly, and Gayathri R. Devi. “X-linked inhibitor of apoptosis protein inhibits apoptosis in inflammatory breast cancer cells with acquired resistance to an ErbB1/2 tyrosine kinase inhibitor.” Mol Cancer Ther 9, no. 5 (May 2010): 1432–42. https://doi.org/10.1158/1535-7163.MCT-10-0160.More info
- Hartman, Zachary C., Junping Wei, Takuya Osada, Oliver Glass, Gangjun Lei, Xiao-Yi Yang, Sharon Peplinski, et al. “An adenoviral vaccine encoding full-length inactivated human Her2 exhibits potent immunogenicty and enhanced therapeutic efficacy without oncogenicity.” Clin Cancer Res 16, no. 5 (March 1, 2010): 1466–77. https://doi.org/10.1158/1078-0432.CCR-09-2549.More info
- Osada, T., D. Hsu, S. Hammond, A. Hobeika, G. Devi, T. M. Clay, H. K. Lyerly, and M. A. Morse. “Metastatic colorectal cancer cells from patients previously treated with chemotherapy are sensitive to T-cell killing mediated by CEA/CD3-bispecific T-cell-engaging BiTE antibody.” Br J Cancer 102, no. 1 (January 5, 2010): 124–33. https://doi.org/10.1038/sj.bjc.6605364.More info
- Hsu, D. S., M. Morse, T. Clay, G. Devi, and H. Kim Lyerly. “Immune Cells and the Tumor Microenvironment.” In Genomic and Personalized Medicine, Two-Vol Set, 818–29, 2009. https://doi.org/10.1016/B978-0-12-369420-1.00068-8.More info
- Iversen, Patrick L., Katherine M. Aird, Rebecca Wu, Michael M. Morse, and Gayathri R. Devi. “Cellular uptake of neutral phosphorodiamidate morpholino oligomers.” Curr Pharm Biotechnol 10, no. 6 (September 2009): 579–88. https://doi.org/10.2174/138920109789069279.More info
- Ding, X., A. B. Mohd, Z. Huang, T. Baba, M. Q. Bernardini, H. K. Lyerly, A. Berchuck, S. K. Murphy, A. B. Buermeyer, and G. R. Devi. “MLH1 expression sensitises ovarian cancer cells to cell death mediated by XIAP inhibition.” Br J Cancer 101, no. 2 (July 21, 2009): 269–77. https://doi.org/10.1038/sj.bjc.6605180.More info
- Mavropoulos, John C., W Cooper Buschemeyer, Alok K. Tewari, Dmitriy Rokhfeld, Michael Pollak, Yunhua Zhao, Phillip G. Febbo, et al. “The effects of varying dietary carbohydrate and fat content on survival in a murine LNCaP prostate cancer xenograft model.” Cancer Prev Res (Phila) 2, no. 6 (June 2009): 557–65. https://doi.org/10.1158/1940-6207.CAPR-08-0188.More info
- Devi, Gayathri R. “Delivery of phosphorodiamidate morpholino antisense oligomers in cancer cells.” Methods Mol Biol 542 (2009): 351–61. https://doi.org/10.1007/978-1-59745-561-9_19.More info
- Hsu, D. S., M. Morse, T. Clay, G. Devi, and H. K. Lyerly. “Immune Cells and the Tumor Microenvironment.” In Genomic and Personalized Medicine: V1-2, 818–29, 2008. https://doi.org/10.1016/B978-0-12-369420-1.00068-8.More info
- Sekhon, Harmanjatinder S., Carla A. London, Mypinder Sekhon, Patrick L. Iversen, and Gayathri R. Devi. “c-MYC antisense phosphosphorodiamidate morpholino oligomer inhibits lung metastasis in a murine tumor model.” Lung Cancer 60, no. 3 (June 2008): 347–54. https://doi.org/10.1016/j.lungcan.2007.10.028.More info
- Aird, Katherine M., Xiuyun Ding, Aris Baras, Junping Wei, Michael A. Morse, Timothy Clay, Herbert K. Lyerly, and Gayathri R. Devi. “Trastuzumab signaling in ErbB2-overexpressing inflammatory breast cancer correlates with X-linked inhibitor of apoptosis protein expression.” Mol Cancer Ther 7, no. 1 (January 2008): 38–47. https://doi.org/10.1158/1535-7163.MCT-07-0370.More info
- Morse, Michael A., Amy Hobeika, Takuya Osada, Donna Niedzwiecki, Paul Kelly Marcom, Kimberly L. Blackwell, Carey Anders, Gayathri R. Devi, H Kim Lyerly, and Timothy M. Clay. “Long term disease-free survival and T cell and antibody responses in women with high-risk Her2+ breast cancer following vaccination against Her2.” J Transl Med 5 (September 6, 2007): 42. https://doi.org/10.1186/1479-5876-5-42.More info
- Devi, G. R. “siRNA-based approaches in cancer therapy.” Cancer Gene Ther 13, no. 9 (September 2006): 819–29. https://doi.org/10.1038/sj.cgt.7700931.More info
- Baras, Aris I., Ian Cushman, Yiting Cao, Herbert K. Lyerly, Mark Dewhirst, Patrick Casey, and Gayathri R. Devi. “Development of cellular models and small GTPases-targeted therapeutics for inflammatory breast cancer.” In CANCER RESEARCH, Vol. 66. AMER ASSOC CANCER RESEARCH, 2006.More info
- Devi, Gayathri R., Tomasz M. Beer, Christopher L. Corless, Vikram Arora, Doreen L. Weller, and Patrick L. Iversen. “In vivo bioavailability and pharmacokinetics of a c-MYC antisense phosphorodiamidate morpholino oligomer, AVI-4126, in solid tumors.” Clin Cancer Res 11, no. 10 (May 15, 2005): 3930–38. https://doi.org/10.1158/1078-0432.CCR-04-2091.More info
- Devi, G. R. “Genomics-based anti-cancer drug discovery - Preface.” CURRENT PHARMACEUTICAL BIOTECHNOLOGY. BENTHAM SCIENCE PUBL LTD, October 1, 2004.More info
- Arora, Vikram, Gayathri R. Devi, and Patrick L. Iversen. “Neutrally charged phosphorodiamidate morpholino antisense oligomers: uptake, efficacy and pharmacokinetics.” Curr Pharm Biotechnol 5, no. 5 (October 2004): 431–39. https://doi.org/10.2174/1389201043376706.More info
- Devi, G. R. “Preface.” Current Pharmaceutical Biotechnology, October 1, 2004.More info
- Ko, Yoo-Joung, Gayathri R. Devi, Carla A. London, Anthony Kayas, Muralimohan T. Reddy, Patrick L. Iversen, Glenn J. Bubley, and Steven P. Balk. “Androgen receptor down-regulation in prostate cancer with phosphorodiamidate morpholino antisense oligomers.” J Urol 172, no. 3 (September 2004): 1140–44. https://doi.org/10.1097/01.ju.0000134698.87862.e6.More info
- Amantana, Adams, Carla A. London, Patrick L. Iversen, and Gayathri R. Devi. “X-linked inhibitor of apoptosis protein inhibition induces apoptosis and enhances chemotherapy sensitivity in human prostate cancer cells.” Mol Cancer Ther 3, no. 6 (June 2004): 699–707.More info
- Devi, Gayathri R. “XIAP as target for therapeutic apoptosis in prostate cancer.” Drug News Perspect 17, no. 2 (March 2004): 127–34. https://doi.org/10.1358/dnp.2004.17.2.829046.More info
- Ko, Y. J., G. R. Devi, C. A. London, A. Kayas, M. T. Reddy, P. L. Iverson, G. J. Bubley, and S. P. Balk. “Androgen receptor downregulation in prostate cancer with phosphorodiamidate morpholino antisense oligomers.” In CLINICAL CANCER RESEARCH, 9:6084S-6084S. AMER ASSOC CANCER RESEARCH, 2003.More info
- London, Carla A., Harmanjatinder S. Sekhon, Vikram Arora, David A. Stein, Patrick L. Iversen, and Gayathri R. Devi. “A novel antisense inhibitor of MMP-9 attenuates angiogenesis, human prostate cancer cell invasion and tumorigenicity.” Cancer Gene Ther 10, no. 11 (November 2003): 823–32. https://doi.org/10.1038/sj.cgt.7700642.More info
- Iversen, Patrick L., Vikram Arora, A. J. Acker, David H. Mason, and Gayathri R. Devi. “Efficacy of antisense morpholino oligomer targeted to c-myc in prostate cancer xenograft murine model and a Phase I safety study in humans.” Clin Cancer Res 9, no. 7 (July 2003): 2510–19.More info
- Devi, G. “Gene Therapy of Cancer - 11th International Conference: 12-14 December 2002, San Diego, USA.” In IDrugs, 6:104–6, 2003.More info
- Knapp, Derek C., John E. Mata, Muralimohan T. Reddy, Gayathri R. Devi, and Patrick L. Iversen. “Resistance to chemotherapeutic drugs overcome by c-Myc inhibition in a Lewis lung carcinoma murine model.” Anticancer Drugs 14, no. 1 (January 2003): 39–47. https://doi.org/10.1097/00001813-200301000-00006.More info
- London, C. A., D. C. Knapp, Y. J. Ko, S. Balk, M. DeSouza, D. H. Farrell, P. L. Iversen, and G. R. Devi. “In vivo efficacy of phosphorodiamidate morpholino-based antisense oligomers in tumor and angiogenesis models.” In CANCER GENE THERAPY, 10:S3–4. NATURE PUBLISHING GROUP, 2003.More info
- De Sousa, M. A., M. H. Davies, C. A. London, M. R. Powers, G. R. Devi, and D. H. Farrell. “Morpholino antisense oligomer to integrin alpha, inhibits angiogenesis in a mouse model of retinopathy of prematurity.” In BLOOD, 100:680A-680A. AMER SOC HEMATOLOGY, 2002.More info
- Devi, Gayathri R., Jennifer R. Oldenkamp, Carla A. London, and Patrick L. Iversen. “Inhibition of human chorionic gonadotropin beta-subunit modulates the mitogenic effect of c-myc in human prostate cancer cells.” Prostate 53, no. 3 (November 1, 2002): 200–210. https://doi.org/10.1002/pros.10151.More info
- Devi, Gayathri R., Cynthia C. Sprenger, Stephen R. Plymate, and Ron G. Rosenfeld. “Insulin-like growth factor binding protein-3 induces early apoptosis in malignant prostate cancer cells and inhibits tumor formation in vivo.” Prostate 51, no. 2 (May 1, 2002): 141–52. https://doi.org/10.1002/pros.10068.More info
- De Sousa, M. A., J. D. Bird, C. A. London, P. L. Iversen, G. R. Devi, and D. H. Farrell. “Inhibition of tumor growth using an antisense morpholino oligomer to integrin alpha(v) subunit.” In ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 22:A15–A15. LIPPINCOTT WILLIAMS & WILKINS, 2002.More info
- Devi, Gayathri R. “Prostate cancer: status of current treatments and emerging antisense-based therapies.” Curr Opin Mol Ther 4, no. 2 (April 2002): 138–48.More info
- Devi, G. R., J. R. Oldenkamp, and P. L. Iversen. “Inhibition of human chorionic gonadotropin beta-subunit modulates the mitogenic effect of c-myc in human prostate cancer cells.” In CANCER GENE THERAPY, 8:S6–S6. NATURE PUBLISHING GROUP, 2001.More info
- Devi, G. R., D. L. Graham, Y. Oh, and R. G. Rosenfeld. “Effect of IGFBP-3 on IGF- and IGF-analogue-induced insulin-like growth factor-I receptor (IGFIR) signalling.” Growth Horm IGF Res 11, no. 4 (August 2001): 231–39. https://doi.org/10.1054/ghir.2001.0231.More info
- López-Bermejo, A., C. K. Buckway, G. R. Devi, V. Hwa, S. R. Plymate, Y. Oh, and R. G. Rosenfeld. “Characterization of insulin-like growth factor-binding protein-related proteins (IGFBP-rPs) 1, 2, and 3 in human prostate epithelial cells: potential roles for IGFBP-rP1 and 2 in senescence of the prostatic epithelium.” Endocrinology 141, no. 11 (November 2000): 4072–80. https://doi.org/10.1210/endo.141.11.7783.More info
- Lo Pez-Bermejo, A., C. K. Buckway, G. R. Devi, V. Hwa, S. R. Plymate, Y. Oh, and R. G. Rosenfeld. “Characterization of Insulin-Like Growth Factor-Binding Protein-Related Proteins (IGFBP-rPs) 1, 2, and 3 in Human Prostate Epithelial Cells: Potential Roles for IGFBP-rP1 and 2 in Senescence of the Prostatic Epithelium.” Endocrinology 141, no. 11 (November 1, 2000): 4072–80. https://doi.org/10.1210/endo.141.11.7783.More info
- Devi, Gayathri R., Doo-Hyun Yang, Ron G. Rosenfeld, and Youngman Oh. “Differential Effects of Insulin-Like Growth Factor (IGF)-Binding Protein-3 and Its Proteolytic Fragments on Ligand Binding, Cell Surface Association, and IGF-I Receptor Signaling* * This research was supported by US Army Grants DAMD17-991-9522 (to G.R.D.) and DAMD17-96-1-6204 and DAMD17-96-1-7204 (to Y.O.H.) and by NIH Grants R01-DK-51513 (to R.G.R.) and CA-58110 (to R.G.R.).” Endocrinology 141, no. 11 (November 1, 2000): 4171–79. https://doi.org/10.1210/endo.141.11.7781.More info
- Devi, G. R., D. H. Yang, R. G. Rosenfeld, and Y. Oh. “Differential effects of insulin-like growth factor (IGF)-binding protein-3 and its proteolytic fragments on ligand binding, cell surface association, and IGF-I receptor signaling.” Endocrinology 141, no. 11 (November 2000): 4171–79. https://doi.org/10.1210/endo.141.11.7781.More info
- Rosenfeld, R. G., V. Hwa, L. Wilson, A. Lopez-Bermejo, C. Buckway, C. Burren, W. K. Choi, et al. “The insulin-like growth factor binding protein superfamily: new perspectives.” Pediatrics 104, no. 4 Pt 2 (October 1999): 1018–21.More info
- Devi, G. R., A. T. De Souza, J. C. Byrd, R. L. Jirtle, and R. G. MacDonald. “Altered ligand binding by insulin-like growth factor II/mannose 6-phosphate receptors bearing missense mutations in human cancers.” Cancer Res 59, no. 17 (September 1, 1999): 4314–19.More info
- Byrd, J. C., G. R. Devi, A. T. de Souza, R. L. Jirtle, and R. G. MacDonald. “Disruption of ligand binding to the insulin-like growth factor II/mannose 6-phosphate receptor by cancer-associated missense mutations.” J Biol Chem 274, no. 34 (August 20, 1999): 24408–16. https://doi.org/10.1074/jbc.274.34.24408.More info
- Devi, G. R., J. C. Byrd, D. H. Slentz, and R. G. MacDonald. “An insulin-like growth factor II (IGF-II) affinity-enhancing domain localized within extracytoplasmic repeat 13 of the IGF-II/mannose 6-phosphate receptor.” Mol Endocrinol 12, no. 11 (November 1998): 1661–72. https://doi.org/10.1210/mend.12.11.0192.More info
- Garmroudi, F., G. Devi, D. H. Slentz, B. S. Schaffer, and R. G. MacDonald. “Truncated forms of the insulin-like growth factor II (IGF-II)/mannose 6-phosphate receptor encompassing the IGF-II binding site: characterization of a point mutation that abolishes IGF-II binding.” Mol Endocrinol 10, no. 6 (June 1996): 642–51. https://doi.org/10.1210/mend.10.6.8776724.More info
